Skip to content

Clinical trials

Completed Hepatitis C trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Status: Completed Country / region: United States Clear all

552 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20018
200213
200313
200416
200522
200620
200724
200824
200934
201039
201151
201235
201332
201441
201535
201622
201730
201816
201919
202011
20218
20227
20236
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed552

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences69
Bristol-Myers Squibb43
National Institute of Allergy and Infectious Diseases (NIAID)27
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)19
AbbVie12
Vertex Pharmaceuticals Incorporated12
Abbott10
GlaxoSmithKline10
Icahn School of Medicine at Mount Sinai10
Johns Hopkins University10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C552
Hepatitis C, Chronic91
HIV Infections53
Fibrosis38
Acquired Immunodeficiency Syndrome37
Liver Diseases36
Hepatitis34
Hepatitis B20
Substance-Related Disorders20
Carcinoma, Hepatocellular14

Trials

Showing 1 to 25 of 552. Each trial links to its page on Pharma Observatory.

452 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.